Here are the top stocks ideas by KRChoksey for April 2023

HDFC Bank, Asian Paints, CreditAccess Grameen, Rossari Biotech, Tata Consumer Products and Godrej Consumer Products are among the top ideas for April 2023.

Rakesh Patil
April 07, 2023 / 07:24 AM IST
Sensex
1/7
The market rally continued for a fifth consecutive session on April 6, after the Reserve Bank of India's Monetary Policy Committee (MPC) surprisingly decided to keep the key interest rate unchanged. At close, the Sensex was up 143.66 points or 0.24 percent at 59,832.97, and the Nifty was up 42.10 points or 0.24 percent at 17,599.20.
Asian Paints | Rating: Buy | Target Price: Rs 3,564 | Upside: 28.3 percent. Broking house expect revenue/ EBITDA/ Adj. PAT to grow at 15.9%/24.2%/ 25.5% CAGR, respectively, between FY22-25E.
2/7
Asian Paints | Rating: Buy | Target Price: Rs 3,564 | Upside: 28.3 percent. The roking house expects revenue/ EBITDA/ Adj. PAT to grow at 15.9 percent/24.2 percent/ 25.5 percent CAGR, respectively, between FY22-25E.
CreditAccess Grameen | Rating: Buy | Target Price: Rs 1,290 | Upside: 40.2 percent. Research firm believes the company will continue to aggressively focus on customer acquisition and benefit from various government initiatives to boost the MFI segment.
3/7
CreditAccess Grameen | Rating: Buy | Target Price: Rs 1,290 | Upside: 40.2 percent. The research firm believes the company will continue to aggressively focus on customer acquisition and benefit from various government initiatives to boost the MFI segment.
Godrej Consumer Products | Rating: Buy | Target Price: Rs 1,110 | Upside: 15 percent. Brokerage firm expect overall Revenue/EBITDA/Adj. PAT to increase by 10.6%/14.3%/11.3% respectively over FY22-25E.
4/7
Godrej Consumer Products | Rating: Buy | Target Price: Rs 1,110 | Upside: 15 percent. The brokerage firm expects overall Revenue/EBITDA/Adj. PAT to increase by 10.6 percent/14.3 percent/11.3 percent respectively over FY22-25E.
HDFC Bank | Rating: Buy | Target Price: Rs 1,960 | Upside: 21.7 percent. With HDFC's leadership in the housing loan sector, HDFC Bank will be able to provide its customers with flexible mortgage products cost-effectively. Thus, the merger is expected to strengthen HDFC Bank's capital base and enhance its balance sheet.
5/7
HDFC Bank | Rating: Buy | Target Price: Rs 1,960 | Upside: 21.7 percent. With HDFC's leadership in the housing loan sector, HDFC Bank will be able to provide its customers with flexible mortgage products cost-effectively. Thus, the merger is expected to strengthen HDFC Bank's capital base and enhance its balance sheet.
Tata Consumer Products | Rating: Buy | Target Price: Rs 964 | Upside: 34.5 percent. Broking house expect Revenue/ EBITDA/ Adj. PAT to grow by 9.9%/ 15.2%/ 17.7% CAGR, respectively, over FY22-25E.
6/7
Tata Consumer Products | Rating: Buy | Target Price: Rs 964 | Upside: 34.5 percent. The broking house expects Revenue/ EBITDA/ Adj. PAT to grow by 9.9 percent/ 15.2 percent/ 17.7 percent CAGR, respectively, over FY22-25E.
Rossari Biotech | Rating: Buy | Target Price: Rs 747 | Upside: 24v percent. Research firm estimate PAT to grow at 35.5% CAGR over FY22-24E with EBITDA margin range of 13.5% - 15%.
7/7
Rossari Biotech | Rating: Buy | Target Price: Rs 747 | Upside: 24v percent. The research firm estimate PAT to grow at 35.5 percent CAGR over FY22-24E with an EBITDA margin range of 13.5 - 15 percent.
Rakesh Patil
Tags: #Nifty #Sensex #Slideshow #Stocks Views
first published: Apr 7, 2023 07:24 am